世界華文媒體(00685.HK)擬535.6萬美元出售物業
格隆匯2月28日丨世界華文媒體(00685.HK)公吿,於2024年2月28日,公司全資附屬公司南洋報業控股有限公司("賣方")與Success Oracle Sdn.Bhd.("買方")訂立買賣協議,以出售位於No25,Jalan Industri1/1,Rawang Integrated Industry Park,48000Rawang, Selangor,Malaysia在兩塊永久業權土地上興建四層高辦公大樓及單層廠房("該物業"),總代價為約535.6萬美元,惟須受限於現有租約及買賣協議規定其他條款。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.